ID: ALA1778342

Max Phase: Preclinical

Molecular Formula: C31H35ClN2O7

Molecular Weight: 583.08

Molecule Type: Small molecule

Representations

Canonical SMILES:  COc1cccc([C@H]2O[C@H](CC(=O)N3CCC(CC(=O)O)CC3)c3noc(C(C)C)c3-c3ccc(Cl)cc32)c1OC

Standard InChI:  InChI=1S/C31H35ClN2O7/c1-17(2)29-27-20-9-8-19(32)15-22(20)30(21-6-5-7-23(38-3)31(21)39-4)40-24(28(27)33-41-29)16-25(35)34-12-10-18(11-13-34)14-26(36)37/h5-9,15,17-18,24,30H,10-14,16H2,1-4H3,(H,36,37)/t24-,30-/m1/s1

Standard InChI Key:  YQGPZWOFUCOMGM-AYWVHJORSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 583.08

Molecular Weight (Monoisotopic): 582.2133

AlogP: 6.40

#Rotatable Bonds: 8

Polar Surface Area: 111.33

Molecular Species: ACID

HBA: 7

HBD: 1

#RO5 Violations: 2

HBA (Lipinski): 9

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 4.04

CX Basic pKa:

CX LogP: 4.68

CX LogD: 1.55

Aromatic Rings: 3

Heavy Atoms: 41

QED Weighted: 0.32

Np Likeness Score: -0.39

References

1. Griebenow N, Buchmueller A, Kolkhof P, Schamberger J, Bischoff H..  (2011)  Identification of 4H,6H-[2]benzoxepino[4,5-c][1,2]oxazoles as novel squalene synthase inhibitors.,  21  (12): [PMID:21576018] [10.1016/j.bmcl.2011.04.092]

Source

Source(1):

• Scientific Literature